leukemia
137 projects
H2020Individual fellowship2021–2024Luxembourg
EVIL · Reprogramming of the leukemic microenvironment by small extracellular vesicles: from characterization to therapeutic application
H2020Individual fellowship2021–2023Spain
scGATA2track · Single cell tracking of malignant transformation in GATA2 deficiency
H2020Individual fellowship2021–2023Spain
StemTarget · Development of new therapeutic treatments targeting cancer stem cells.
H2020Individual fellowship2021–2023United Kingdom
BoneImaging · Cryo analytical microscopy of cell-mediated mineralization in models of bone disease
H2020Individual fellowship2021–2024France
MITHAML · Exploring the role of Metabolic IntraTumoral Heterogeneity in drug resistance of Acute Myeloid Leukemia in vivo
2 partners · 2 countries
H2020Individual fellowship2021–2023Spain
SENAGE · Senescence as a key factor in leukemogenesis and bone marrow homeostasis in aging
H2020Individual fellowship2021–2023Germany
TFNup · Molecular, Structural, and Functional Studies of Leukemia-Associated Transcription Factor-Nucleoporin Fusion Proteins
H2020Individual fellowship2020–2022United Kingdom
SALMYB · MYB rearrangements in Adenoid Cystic Carcinoma: protagonists or secondary characters?
H2020Individual fellowship2020–2022United Kingdom
PAC Synthesis · Synthesis of PROTAC-Antibody Conjugate for Application in Acute Myeloid Leukemia Therapy
H2020Individual fellowship2020–2022Spain
SirT-IMLEU · Mechanisms of Sirtuin-dependent regulation of immunity and leukemogenesis
H2020Individual fellowship2020–2022Netherlands
Catenin-Condensation · The effect of β-catenin condensation on the Wnt-pathway
H2020Individual fellowship2020–2022Spain
PRECISMEDLYM · Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine.
H2020Individual fellowship2020–2022United Kingdom
CATKERB · Total Syntheses of Catharanthine and Keramaphidin B by an Iridium-Catalyzed Reductive Cyclization Cascade
H2020Individual fellowship2020–2022United Kingdom
ChRONAM-H · Chromatin Regulation Of Normal And Malignant Haematopoiesis
H2020Individual fellowship2020–2022Spain
LINKER · Elucidating transcriptional rewiring on hematological malignancies via computational methods
H2020Individual fellowship2020–2022United Kingdom
RECOBIN-PROTACs · Reversible Covalently Binding PROTACs Technology for Protein Degradation in Cancer Therapy
H2020Individual fellowship2020–2022Italy
Mitobetes · The role of Von Willebrand Domain-containing Protein 8 in mitochondrial physiology
H2020Individual fellowship2020–2022France
PMLingAML · Using PML nuclear body biology to identify potential AML treatment targets
H2020Individual fellowship2020–2022Italy
IDEAL · Inhibitor of DUX4-IGH to Erase Acute lymphoblastic Leukaemia
H2020Individual fellowship2020–2022Spain
SyLeNCe · Synapses between Leukaemia and its Neighbouring Cells
H2020Doctoral network2019–2023Italy
ARCH · AGE-RELATED CHANGES IN HEMATOPOIESIS
19 partners · 10 countries
H2020Individual fellowship2019–2021Spain
PhotoStem · Photoswitching molecules for the spatiotemporal control of cancer stem cells with light
H2020Individual fellowship2019–2021Spain
Exh-Res-CART · Exhaustion-resistant CAR-T cells for the treatment of solid tumours
H2020Individual fellowship2019–2021Belgium